Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Influenza and Other Respiratory Viruses|April 1, 2019
Inter-seasonality of influenza in AustraliaAye M Moa, Dillon C Adam, C Raina MacIntyreThe Medical Journal of Australia|June 3, 2008
Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in AustraliaKaren Canfell, Emily Banks, Aye M Moa, et al.Heart (British Cardiac Society)|October 1, 2016
Influenza vaccine as a coronary intervention for prevention of myocardial infarctionC Raina MacIntyre, Abela Mahimbo, Aye M Moa, et al.Vaccine|February 10, 2024
Cost-benefit of influenza vaccination in preventing sudden cardiac arrest amongst Australian adultsJenny Wei, Timothy C Tan, Aye M Moa, et al.Influenza and Other Respiratory Viruses|September 29, 2021
Modelling the influenza disease burden in people aged 50-64 and ≥65 years in AustraliaAye M Moa, Robert I Menzies, J Kevin Yin, et al.Influenza and Other Respiratory Viruses|September 22, 2016
Epidemiology of influenza B in Australia: 2001-2014 influenza seasonsAye M Moa, David J Muscatello, Robin M Turner, et al.Plos One|April 14, 2020
Estimated hospitalisations attributable to seasonal and pandemic influenza in Australia: 2001- 2013Aye M Moa, David J Muscatello, Robin M Turner, et al.Vaccines|October 28, 2025
The Burden of Pertussis Disease and Vaccination Coverage in Australian Adults Attending Primary Health CareAye M Moa, Juan C Vargas-Zambrano, Hubert Maruszak, et al.Vaccines|May 7, 2025
Prevention of Cardiovascular Diseases with Standard-Dose Quadrivalent Influenza Vaccine in People Aged ≥50 Years in Australia During the 2017 A/H3N2 EpidemicZubair Akhtar, Aye M Moa, Timothy C Tan, et al.Vaccine|July 7, 2016
Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trialsAye M Moa, Abrar A Chughtai, David J Muscatello, et al.Pageof 2